Identification
- Brand Name
- Truvada
- Product Description
- Truvada is a prescription HIV nucleoside analog reverse transcriptase inhibitor (HIV NRTI) available in multiple countries including the United States, Canada, Italy, and the EU. It was first marketed in 2004. It is available in an Oral Tablet, film-coated, an Oral Tablet, coated, and an Oral Tablet. It contains two active ingredients: Emtricitabine and Tenofovir disoproxil, in its salt form Tenofovir disoproxil fumarate. Emtricitabine is a medication used to treat and prevent HIV. Tenofovir disoproxil is a medication used to treat hepatitis B infection and to manage HIV infection.
- Ingredients
Drug Salt Emtricitabine Not Available Tenofovir disoproxil Tenofovir disoproxil fumarate
Pharmacology
- Indications
- Used as adjunct in combination for Weight Gain in a regimen PrescriptionUsed as adjunct in combination to treat Human Immunodeficiency Virus Type 1 (HIV-1) Infection in a combination product PrescriptionUsed in combination for prophylaxis of Human Immunodeficiency Virus Type 1 (HIV-1) Infection in a combination product PrescriptionUsed in combination to treat Human Immunodeficiency Virus Type 1 (HIV-1) Infection in a regimen Prescription
- Products
Dosage Strength Route Labeller Marketing Start Marketing End NDC Code Tablet Oral Gilead Sciences 2006-04-06 - Canada 
02274906Tablet, film coated Oral Gilead Sciences, Inc 2016-03-10 - US 
61958-0704Tablet, film coated Oral Gilead Sciences, Inc 2004-08-02 - US 61958-0701Tablet, film coated Oral Gilead Sciences, Inc 2016-03-10 - US 61958-0705Tablet, film coated Oral Gilead Sciences, Inc 2016-03-10 - US 61958-0703Tablet, film coated Oral H.J. Harkins Company 2004-08-02 - US 52959-969Tablet, film coated Oral Physicians Total Care, Inc. 2004-08-02 - US 54868-5141Tablet, film coated Oral REMEDYREPACK INC. 2016-12-30 - US 70518-0097Tablet, film coated Oral RedPharm Drug, Inc. 2004-08-02 - US 67296-1237Tablet, film coated Oral bryant ranch prepack 2004-08-02 - US 63629-7581Tablet, film coated Oral A-S Medication Solutions 2004-08-02 - US 50090-0870Tablet, film coated Oral Nucare Pharmaceuticals,inc. 2004-08-02 - US 68071-2112Tablet, film coated Oral Cardinal Health 2004-08-02 2016-12-31 US 55154-0082Tablet, film coated Oral Lake Erie Medical DBA Quality Care Products LLC 2004-08-02 2019-10-11 US 35356-070Tablet, film coated Oral Direct Rx 2017-02-22 - US 61919-669Tablet, film coated Oral State of Florida DOH Central Pharmacy 2009-07-01 - US 53808-0805Tablet, film coated Oral Cardinal Health 2004-08-02 2015-08-31 US 55154-4425Tablet, film coated Oral Avera McKennan Hospital 2015-05-01 - US 69189-0701Tablet, film coated Oral A-S Medication Solutions 2004-08-02 - US 54569-5588Tablet, film coated Oral Remedy Repack 2016-02-17 2016-11-11 US 61786-596Tablet, film coated Oral Clinical Solutions Wholsesale 2004-08-02 2017-06-15 US 58118-0100
Interactions
- Drug Interaction Search
- Warning: If no interactions are found between two drugs, it does not necessarily mean that no interactions exist. Always consult with a healthcare professional.This interaction checker is limited to 5 drugs at once, available for educational and information purposes only. It is not representative of the full commercial version, which integrates into your products. Learn more
- All Drug Interactions
- Show all
Drug Interaction Integrate drug-drug
interactions in your softwareAbacavir Tenofovir disoproxil may decrease the excretion rate of Abacavir which could result in a higher serum level. Abemaciclib The excretion of Abemaciclib can be decreased when combined with Emtricitabine. Abemaciclib The serum concentration of Abemaciclib can be increased when it is combined with Tenofovir disoproxil. Abrocitinib The serum concentration of Tenofovir disoproxil can be increased when it is combined with Abrocitinib. Aceclofenac Aceclofenac may increase the nephrotoxic activities of Tenofovir disoproxil. Acemetacin Acemetacin may increase the nephrotoxic activities of Tenofovir disoproxil. Acetaminophen Tenofovir disoproxil may decrease the excretion rate of Acetaminophen which could result in a higher serum level. Acetazolamide Acetazolamide may increase the excretion rate of Tenofovir disoproxil which could result in a lower serum level and potentially a reduction in efficacy. Acetylsalicylic acid Acetylsalicylic acid may increase the nephrotoxic activities of Tenofovir disoproxil. Aclidinium Tenofovir disoproxil may decrease the excretion rate of Aclidinium which could result in a higher serum level. 
Identify potential medication risksEasily compare up to 40 drugs with our drug interaction checker.Get severity rating, description, and management advice.Learn more